| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Science | 13 | 2012 | 239 | 2.730 |
Why?
|
| Crystallography, X-Ray | 101 | 2021 | 1990 | 2.360 |
Why?
|
| Protein Conformation | 140 | 2021 | 3968 | 2.250 |
Why?
|
| Research | 18 | 2013 | 1982 | 2.190 |
Why?
|
| Biomedical Research | 19 | 2022 | 3429 | 2.180 |
Why?
|
| Research Support as Topic | 16 | 2012 | 697 | 2.030 |
Why?
|
| Models, Molecular | 130 | 2018 | 5439 | 1.740 |
Why?
|
| Endosomes | 10 | 2024 | 522 | 1.580 |
Why?
|
| Biological Evolution | 16 | 2009 | 1071 | 1.510 |
Why?
|
| Genomics | 26 | 2012 | 5821 | 1.480 |
Why?
|
| Proteins | 32 | 2014 | 6032 | 1.410 |
Why?
|
| Bioterrorism | 9 | 2012 | 144 | 1.330 |
Why?
|
| National Institutes of Health (U.S.) | 11 | 2012 | 793 | 1.320 |
Why?
|
| Research Personnel | 9 | 2012 | 588 | 1.300 |
Why?
|
| Biology | 5 | 2010 | 290 | 1.230 |
Why?
|
| Enzymes | 12 | 2009 | 257 | 1.230 |
Why?
|
| Awards and Prizes | 2 | 2022 | 360 | 1.170 |
Why?
|
| Genome | 6 | 2016 | 1740 | 1.010 |
Why?
|
| Crystallization | 46 | 2014 | 534 | 0.950 |
Why?
|
| Peer Review, Research | 7 | 2012 | 340 | 0.940 |
Why?
|
| Triose-Phosphate Isomerase | 25 | 1999 | 45 | 0.930 |
Why?
|
| Binding Sites | 100 | 2022 | 6056 | 0.920 |
Why?
|
| X-Ray Diffraction | 65 | 2016 | 421 | 0.890 |
Why?
|
| Parkinson Disease | 15 | 2022 | 2877 | 0.870 |
Why?
|
| Catalysis | 43 | 2018 | 774 | 0.850 |
Why?
|
| Molecular Biology | 5 | 2010 | 576 | 0.830 |
Why?
|
| Carbohydrate Epimerases | 24 | 2003 | 46 | 0.820 |
Why?
|
| Religion and Science | 3 | 2008 | 4 | 0.800 |
Why?
|
| Politics | 10 | 2012 | 815 | 0.770 |
Why?
|
| Genome, Human | 12 | 2012 | 4425 | 0.760 |
Why?
|
| Pseudomonas putida | 15 | 2017 | 49 | 0.750 |
Why?
|
| Midwifery | 1 | 2022 | 125 | 0.730 |
Why?
|
| Protein Folding | 14 | 2011 | 870 | 0.730 |
Why?
|
| Alzheimer Disease | 12 | 2024 | 8601 | 0.720 |
Why?
|
| Aminopeptidases | 8 | 2008 | 95 | 0.720 |
Why?
|
| Dogs | 5 | 2012 | 3839 | 0.710 |
Why?
|
| Alcohol Oxidoreductases | 7 | 1998 | 169 | 0.700 |
Why?
|
| Periodicals as Topic | 7 | 2011 | 1463 | 0.690 |
Why?
|
| Saccharomyces cerevisiae | 24 | 2018 | 2688 | 0.690 |
Why?
|
| Green Fluorescent Proteins | 4 | 2022 | 2065 | 0.690 |
Why?
|
| alpha-Synuclein | 11 | 2022 | 750 | 0.650 |
Why?
|
| Aldose-Ketose Isomerases | 11 | 2004 | 17 | 0.630 |
Why?
|
| Universities | 5 | 2010 | 993 | 0.620 |
Why?
|
| Aeromonas | 6 | 2007 | 16 | 0.620 |
Why?
|
| DNA | 8 | 2022 | 7213 | 0.610 |
Why?
|
| Budgets | 3 | 2010 | 230 | 0.600 |
Why?
|
| Publishing | 5 | 2011 | 833 | 0.590 |
Why?
|
| Oncogene Proteins | 6 | 2014 | 719 | 0.590 |
Why?
|
| Sequence Analysis, DNA | 11 | 2010 | 4740 | 0.590 |
Why?
|
| Protein Structure, Secondary | 18 | 2016 | 1229 | 0.590 |
Why?
|
| Drug Discovery | 5 | 2015 | 1051 | 0.590 |
Why?
|
| Bacterial Proteins | 19 | 2017 | 3847 | 0.590 |
Why?
|
| Humanities | 2 | 2010 | 55 | 0.580 |
Why?
|
| Amino Acid Sequence | 60 | 2021 | 13446 | 0.550 |
Why?
|
| Racemases and Epimerases | 11 | 1998 | 114 | 0.550 |
Why?
|
| Molecular Chaperones | 4 | 2018 | 754 | 0.550 |
Why?
|
| Superoxide Dismutase | 11 | 2024 | 594 | 0.550 |
Why?
|
| Hydro-Lyases | 4 | 2011 | 94 | 0.550 |
Why?
|
| Substrate Specificity | 34 | 2017 | 1791 | 0.540 |
Why?
|
| Drug Industry | 4 | 2011 | 788 | 0.530 |
Why?
|
| Models, Chemical | 9 | 2006 | 611 | 0.530 |
Why?
|
| History, 20th Century | 13 | 2021 | 2767 | 0.520 |
Why?
|
| Adaptor Protein Complex Subunits | 1 | 2015 | 3 | 0.500 |
Why?
|
| Myoglobin | 12 | 2002 | 159 | 0.500 |
Why?
|
| Enzyme Stability | 13 | 2017 | 219 | 0.500 |
Why?
|
| Protein Binding | 42 | 2020 | 9353 | 0.480 |
Why?
|
| Hydrogen Bonding | 22 | 2013 | 291 | 0.480 |
Why?
|
| Federal Government | 5 | 2010 | 267 | 0.480 |
Why?
|
| Chemistry | 5 | 2004 | 347 | 0.470 |
Why?
|
| Escherichia coli | 27 | 2016 | 4217 | 0.470 |
Why?
|
| Sequence Alignment | 10 | 2016 | 2180 | 0.460 |
Why?
|
| Protein Interaction Mapping | 2 | 2011 | 616 | 0.460 |
Why?
|
| Sequence Analysis, Protein | 3 | 2007 | 261 | 0.460 |
Why?
|
| Terminology as Topic | 5 | 2010 | 1530 | 0.450 |
Why?
|
| T-Box Domain Proteins | 1 | 2016 | 469 | 0.450 |
Why?
|
| Kinetics | 44 | 2018 | 6374 | 0.450 |
Why?
|
| Prejudice | 3 | 2008 | 570 | 0.440 |
Why?
|
| Enzyme Inhibitors | 14 | 2018 | 3713 | 0.440 |
Why?
|
| Molecular Imaging | 1 | 2020 | 815 | 0.440 |
Why?
|
| LDL-Receptor Related Proteins | 2 | 2024 | 118 | 0.430 |
Why?
|
| Yersinia pseudotuberculosis | 2 | 2004 | 25 | 0.430 |
Why?
|
| Human Genome Project | 5 | 2009 | 200 | 0.430 |
Why?
|
| Salmonella typhimurium | 7 | 1997 | 347 | 0.430 |
Why?
|
| Saccharomyces cerevisiae Proteins | 8 | 2018 | 1841 | 0.430 |
Why?
|
| Financing, Government | 3 | 2011 | 472 | 0.420 |
Why?
|
| Neurons | 10 | 2022 | 9463 | 0.420 |
Why?
|
| Molecular Sequence Data | 57 | 2014 | 17635 | 0.420 |
Why?
|
| Biotechnology | 3 | 2010 | 282 | 0.420 |
Why?
|
| Glucosylceramidase | 3 | 2009 | 127 | 0.420 |
Why?
|
| Molecular Structure | 35 | 2010 | 1880 | 0.420 |
Why?
|
| Imino Pyranoses | 2 | 2009 | 4 | 0.410 |
Why?
|
| Biological Warfare Agents | 1 | 2012 | 2 | 0.410 |
Why?
|
| Disease | 4 | 2012 | 672 | 0.410 |
Why?
|
| Protein Transport | 12 | 2024 | 1967 | 0.410 |
Why?
|
| Cell Physiological Phenomena | 1 | 2013 | 150 | 0.400 |
Why?
|
| Molecular Motor Proteins | 1 | 2012 | 106 | 0.400 |
Why?
|
| Cysteine | 10 | 2024 | 891 | 0.400 |
Why?
|
| Archaeal Proteins | 2 | 2003 | 57 | 0.400 |
Why?
|
| Animals | 104 | 2024 | 168475 | 0.400 |
Why?
|
| Chymotrypsin | 6 | 2011 | 138 | 0.390 |
Why?
|
| Computational Biology | 10 | 2011 | 3517 | 0.390 |
Why?
|
| Peer Review | 2 | 2012 | 217 | 0.390 |
Why?
|
| Sequence Homology, Amino Acid | 15 | 2018 | 2748 | 0.390 |
Why?
|
| Drug Design | 7 | 2011 | 1048 | 0.390 |
Why?
|
| Hydrogen-Ion Concentration | 13 | 2009 | 2496 | 0.380 |
Why?
|
| RNA-Binding Protein FUS | 2 | 2011 | 76 | 0.380 |
Why?
|
| Spacecraft | 1 | 2011 | 28 | 0.380 |
Why?
|
| Gene Expression | 4 | 2020 | 7581 | 0.380 |
Why?
|
| History, 21st Century | 7 | 2021 | 1567 | 0.380 |
Why?
|
| Protein Multimerization | 9 | 2024 | 983 | 0.370 |
Why?
|
| Pyridoxal Phosphate | 11 | 2018 | 121 | 0.360 |
Why?
|
| Orthomyxoviridae | 1 | 2012 | 149 | 0.360 |
Why?
|
| Humans | 142 | 2024 | 761596 | 0.360 |
Why?
|
| Access to Information | 4 | 2011 | 316 | 0.360 |
Why?
|
| Ethics, Research | 1 | 2012 | 176 | 0.360 |
Why?
|
| Stem Cell Research | 1 | 2010 | 37 | 0.360 |
Why?
|
| Mars | 2 | 2012 | 28 | 0.350 |
Why?
|
| Amyotrophic Lateral Sclerosis | 6 | 2024 | 1469 | 0.350 |
Why?
|
| Mycoplasma | 1 | 2010 | 147 | 0.350 |
Why?
|
| Greenhouse Effect | 2 | 2007 | 31 | 0.350 |
Why?
|
| Ursidae | 1 | 2010 | 26 | 0.350 |
Why?
|
| Steroid Isomerases | 4 | 2013 | 19 | 0.340 |
Why?
|
| Research Design | 5 | 2009 | 6180 | 0.340 |
Why?
|
| Capital Financing | 1 | 2010 | 58 | 0.340 |
Why?
|
| Amyloid beta-Protein Precursor | 4 | 2023 | 1111 | 0.340 |
Why?
|
| Bacillus thuringiensis | 4 | 2013 | 12 | 0.330 |
Why?
|
| Mutagenesis, Site-Directed | 24 | 2017 | 1693 | 0.330 |
Why?
|
| Bioengineering | 1 | 2010 | 99 | 0.330 |
Why?
|
| Genes | 4 | 2002 | 1823 | 0.330 |
Why?
|
| Cell Adhesion Molecules | 3 | 2022 | 1601 | 0.330 |
Why?
|
| Public Policy | 3 | 2010 | 559 | 0.330 |
Why?
|
| Books | 1 | 2009 | 22 | 0.330 |
Why?
|
| Embryo Research | 2 | 2010 | 38 | 0.330 |
Why?
|
| Muramidase | 8 | 2008 | 169 | 0.330 |
Why?
|
| alpha-Galactosidase | 1 | 2009 | 57 | 0.330 |
Why?
|
| Societies, Scientific | 2 | 2008 | 222 | 0.320 |
Why?
|
| Catalytic Domain | 11 | 2017 | 705 | 0.320 |
Why?
|
| Public Opinion | 2 | 2010 | 484 | 0.320 |
Why?
|
| Clinical Trials, Phase II as Topic | 2 | 2018 | 629 | 0.320 |
Why?
|
| Metaphor | 2 | 2007 | 41 | 0.320 |
Why?
|
| Global Warming | 1 | 2009 | 79 | 0.320 |
Why?
|
| Biochemistry | 1 | 2009 | 114 | 0.310 |
Why?
|
| Genetics | 2 | 2006 | 114 | 0.310 |
Why?
|
| Protein Structure, Tertiary | 20 | 2014 | 3792 | 0.310 |
Why?
|
| Trans-Activators | 3 | 2015 | 2856 | 0.310 |
Why?
|
| Dissent and Disputes | 1 | 2009 | 146 | 0.310 |
Why?
|
| Thermodynamics | 19 | 2009 | 595 | 0.310 |
Why?
|
| Population Dynamics | 1 | 2010 | 307 | 0.310 |
Why?
|
| Nuclear Receptor Subfamily 4, Group A, Member 2 | 2 | 2020 | 42 | 0.300 |
Why?
|
| Public Sector | 2 | 2011 | 267 | 0.300 |
Why?
|
| United States | 29 | 2012 | 72340 | 0.300 |
Why?
|
| Photography | 1 | 2011 | 532 | 0.300 |
Why?
|
| Membrane Transport Proteins | 2 | 2024 | 1035 | 0.300 |
Why?
|
| Famous Persons | 1 | 2009 | 109 | 0.300 |
Why?
|
| Influenza, Human | 2 | 2012 | 1521 | 0.300 |
Why?
|
| Disease Outbreaks | 3 | 2006 | 1749 | 0.300 |
Why?
|
| Movement | 2 | 2012 | 1478 | 0.300 |
Why?
|
| Genetic Research | 1 | 2008 | 171 | 0.290 |
Why?
|
| Recombinant Proteins | 20 | 2017 | 6534 | 0.290 |
Why?
|
| Physics | 2 | 2005 | 91 | 0.290 |
Why?
|
| Ubiquitin Thiolesterase | 2 | 2012 | 455 | 0.290 |
Why?
|
| Vesicular Transport Proteins | 3 | 2022 | 376 | 0.290 |
Why?
|
| Carboxylic Ester Hydrolases | 4 | 2008 | 99 | 0.290 |
Why?
|
| Geology | 1 | 2007 | 7 | 0.290 |
Why?
|
| Neuroprotective Agents | 6 | 2020 | 957 | 0.280 |
Why?
|
| Gaucher Disease | 2 | 2009 | 110 | 0.280 |
Why?
|
| Financing, Organized | 4 | 2010 | 204 | 0.280 |
Why?
|
| Transaminases | 6 | 1998 | 199 | 0.280 |
Why?
|
| Dimerization | 11 | 2023 | 891 | 0.280 |
Why?
|
| Water | 11 | 2006 | 1411 | 0.280 |
Why?
|
| Structure-Activity Relationship | 22 | 2021 | 3076 | 0.270 |
Why?
|
| Engineering | 1 | 2007 | 56 | 0.270 |
Why?
|
| Administrative Personnel | 1 | 2008 | 184 | 0.270 |
Why?
|
| Immunoglobulin Fab Fragments | 8 | 2005 | 445 | 0.270 |
Why?
|
| Pancreatic Elastase | 8 | 2006 | 127 | 0.270 |
Why?
|
| Transformation, Genetic | 1 | 2006 | 192 | 0.270 |
Why?
|
| Curriculum | 3 | 2010 | 3743 | 0.270 |
Why?
|
| Evolution, Molecular | 5 | 2013 | 1886 | 0.270 |
Why?
|
| Foxes | 1 | 2006 | 10 | 0.270 |
Why?
|
| Interdisciplinary Communication | 1 | 2012 | 931 | 0.270 |
Why?
|
| Women | 1 | 2008 | 223 | 0.260 |
Why?
|
| Mathematics | 3 | 2006 | 707 | 0.260 |
Why?
|
| Leucine | 4 | 2004 | 548 | 0.260 |
Why?
|
| Anthrax | 2 | 2008 | 87 | 0.260 |
Why?
|
| Vital Statistics | 1 | 2006 | 31 | 0.260 |
Why?
|
| Bacillus anthracis | 2 | 2008 | 122 | 0.260 |
Why?
|
| Exobiology | 1 | 2005 | 8 | 0.260 |
Why?
|
| Religion | 1 | 2009 | 372 | 0.260 |
Why?
|
| Biological Warfare | 2 | 2002 | 24 | 0.260 |
Why?
|
| Escherichia coli Proteins | 3 | 2014 | 1067 | 0.260 |
Why?
|
| Hominidae | 1 | 2006 | 68 | 0.260 |
Why?
|
| Foundations | 1 | 2006 | 95 | 0.260 |
Why?
|
| Biophysics | 2 | 2005 | 380 | 0.260 |
Why?
|
| DNA Helicases | 1 | 2011 | 851 | 0.250 |
Why?
|
| Nuclear Warfare | 1 | 2005 | 30 | 0.250 |
Why?
|
| Serine Proteases | 2 | 2017 | 50 | 0.250 |
Why?
|
| Caspase 1 | 2 | 2016 | 225 | 0.250 |
Why?
|
| Intellectual Property | 1 | 2005 | 31 | 0.250 |
Why?
|
| Intramolecular Lyases | 5 | 2004 | 11 | 0.250 |
Why?
|
| Influenza in Birds | 1 | 2005 | 76 | 0.250 |
Why?
|
| Pseudomonas | 7 | 1993 | 124 | 0.250 |
Why?
|
| Hydralazine | 1 | 2004 | 34 | 0.250 |
Why?
|
| Euthanasia, Passive | 1 | 2005 | 64 | 0.240 |
Why?
|
| Antigens, CD | 3 | 2022 | 4001 | 0.240 |
Why?
|
| Isosorbide Dinitrate | 1 | 2004 | 34 | 0.240 |
Why?
|
| Membrane Proteins | 7 | 2014 | 7859 | 0.240 |
Why?
|
| Women's Rights | 1 | 2005 | 65 | 0.240 |
Why?
|
| Chromatin | 1 | 2016 | 2961 | 0.240 |
Why?
|
| Influenza A Virus, H5N1 Subtype | 1 | 2005 | 113 | 0.240 |
Why?
|
| Models, Economic | 1 | 2009 | 716 | 0.240 |
Why?
|
| Phase Transition | 2 | 2006 | 71 | 0.240 |
Why?
|
| Xylitol | 1 | 2004 | 23 | 0.240 |
Why?
|
| Multiprotein Complexes | 2 | 2015 | 1120 | 0.240 |
Why?
|
| Bacillus subtilis | 4 | 2017 | 351 | 0.230 |
Why?
|
| Policy Making | 1 | 2008 | 542 | 0.230 |
Why?
|
| Stereoisomerism | 12 | 2009 | 614 | 0.230 |
Why?
|
| Models, Theoretical | 5 | 2006 | 3575 | 0.230 |
Why?
|
| Amino Acids | 12 | 2003 | 1718 | 0.230 |
Why?
|
| Drug Approval | 1 | 2011 | 814 | 0.230 |
Why?
|
| Women, Working | 1 | 2005 | 86 | 0.230 |
Why?
|
| Quorum Sensing | 4 | 2013 | 137 | 0.230 |
Why?
|
| Primates | 1 | 2007 | 523 | 0.230 |
Why?
|
| Carboxy-Lyases | 4 | 2009 | 85 | 0.230 |
Why?
|
| Malonates | 1 | 2003 | 43 | 0.230 |
Why?
|
| Isomerases | 5 | 1995 | 55 | 0.230 |
Why?
|
| Dioxygenases | 2 | 2017 | 345 | 0.230 |
Why?
|
| Mutation | 26 | 2024 | 30053 | 0.220 |
Why?
|
| Ligands | 18 | 2020 | 3272 | 0.220 |
Why?
|
| Crystallography | 17 | 1992 | 116 | 0.220 |
Why?
|
| Lysosomes | 1 | 2009 | 924 | 0.220 |
Why?
|
| Yersinia pestis | 1 | 2003 | 33 | 0.220 |
Why?
|
| Streptomyces | 9 | 2004 | 91 | 0.220 |
Why?
|
| Plague | 1 | 2003 | 20 | 0.220 |
Why?
|
| Cisplatin | 3 | 2001 | 1652 | 0.220 |
Why?
|
| Meta-Analysis as Topic | 1 | 2008 | 1380 | 0.220 |
Why?
|
| Ribonuclease, Pancreatic | 4 | 1992 | 149 | 0.210 |
Why?
|
| Periplasmic Binding Proteins | 4 | 1983 | 34 | 0.210 |
Why?
|
| Tetraodontiformes | 1 | 2002 | 12 | 0.210 |
Why?
|
| Point Mutation | 8 | 2013 | 1595 | 0.210 |
Why?
|
| Protein Structure, Quaternary | 4 | 2016 | 429 | 0.210 |
Why?
|
| Art | 1 | 2003 | 64 | 0.210 |
Why?
|
| Nucleic Acid Conformation | 3 | 2004 | 902 | 0.210 |
Why?
|
| Cell Membrane | 2 | 2018 | 3687 | 0.210 |
Why?
|
| Freezing | 7 | 2009 | 311 | 0.210 |
Why?
|
| Cryoprotective Agents | 1 | 2003 | 128 | 0.210 |
Why?
|
| Chemistry, Physical | 6 | 1993 | 154 | 0.210 |
Why?
|
| Spectrum Analysis | 4 | 2020 | 453 | 0.210 |
Why?
|
| Amyloid beta-Peptides | 6 | 2020 | 3839 | 0.210 |
Why?
|
| Dipeptides | 5 | 2016 | 391 | 0.200 |
Why?
|
| Chemical Warfare Agents | 1 | 2002 | 19 | 0.200 |
Why?
|
| Enoyl-CoA Hydratase | 1 | 2002 | 11 | 0.200 |
Why?
|
| DNA, Intergenic | 1 | 2003 | 105 | 0.200 |
Why?
|
| Organisms, Genetically Modified | 1 | 2002 | 63 | 0.200 |
Why?
|
| Ecosystem | 1 | 2007 | 490 | 0.200 |
Why?
|
| Protein Stability | 3 | 2020 | 578 | 0.200 |
Why?
|
| Hot Temperature | 14 | 2017 | 1440 | 0.200 |
Why?
|
| Solvents | 13 | 2009 | 295 | 0.200 |
Why?
|
| Severe Acute Respiratory Syndrome | 1 | 2003 | 137 | 0.200 |
Why?
|
| Microglia | 2 | 2022 | 1362 | 0.200 |
Why?
|
| Triticum | 1 | 2002 | 90 | 0.200 |
Why?
|
| Genome, Plant | 1 | 2002 | 82 | 0.200 |
Why?
|
| Transportation | 1 | 2003 | 217 | 0.200 |
Why?
|
| Proteomics | 4 | 2014 | 3848 | 0.190 |
Why?
|
| Communicable Disease Control | 1 | 2008 | 846 | 0.190 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 4 | 2018 | 509 | 0.190 |
Why?
|
| Zea mays | 1 | 2002 | 112 | 0.190 |
Why?
|
| Aspartic Acid | 4 | 2011 | 576 | 0.190 |
Why?
|
| Thermus thermophilus | 3 | 1998 | 21 | 0.190 |
Why?
|
| Aspartate Aminotransferases | 5 | 2007 | 416 | 0.190 |
Why?
|
| Fluorescence Resonance Energy Transfer | 2 | 2022 | 421 | 0.190 |
Why?
|
| Aldehyde-Lyases | 3 | 2010 | 13 | 0.190 |
Why?
|
| NADP | 6 | 2017 | 227 | 0.190 |
Why?
|
| Mice | 29 | 2024 | 81539 | 0.190 |
Why?
|
| Circular Dichroism | 9 | 2017 | 344 | 0.190 |
Why?
|
| Temperature | 13 | 2005 | 2226 | 0.190 |
Why?
|
| RNA-Directed DNA Polymerase | 1 | 2021 | 225 | 0.180 |
Why?
|
| Genetic Predisposition to Disease | 4 | 2018 | 17904 | 0.180 |
Why?
|
| Nervous System Diseases | 2 | 2015 | 1667 | 0.180 |
Why?
|
| Congresses as Topic | 1 | 2006 | 803 | 0.180 |
Why?
|
| Magnesium | 8 | 1998 | 804 | 0.180 |
Why?
|
| Induced Pluripotent Stem Cells | 3 | 2022 | 1860 | 0.180 |
Why?
|
| Health Care Reform | 1 | 2010 | 1247 | 0.180 |
Why?
|
| Prostaglandins A | 1 | 2020 | 13 | 0.180 |
Why?
|
| Faculty | 3 | 2010 | 384 | 0.180 |
Why?
|
| MEDLINE | 1 | 2000 | 119 | 0.180 |
Why?
|
| Hydroxycholesterols | 1 | 2020 | 25 | 0.180 |
Why?
|
| Forecasting | 2 | 2007 | 2928 | 0.180 |
Why?
|
| Alprostadil | 1 | 2020 | 86 | 0.180 |
Why?
|
| Cell Movement | 1 | 2012 | 5205 | 0.180 |
Why?
|
| Steroid Hydroxylases | 1 | 2020 | 93 | 0.180 |
Why?
|
| Glucose-6-Phosphate Isomerase | 1 | 2000 | 50 | 0.180 |
Why?
|
| Public Health | 2 | 2011 | 2669 | 0.180 |
Why?
|
| Diet, Reducing | 1 | 2003 | 485 | 0.170 |
Why?
|
| Beryllium | 1 | 2000 | 14 | 0.170 |
Why?
|
| Education, Medical, Undergraduate | 2 | 2007 | 1070 | 0.170 |
Why?
|
| HEK293 Cells | 9 | 2024 | 4281 | 0.170 |
Why?
|
| Pharmacogenetics | 1 | 2004 | 675 | 0.170 |
Why?
|
| Sequence Homology, Nucleic Acid | 6 | 2002 | 1058 | 0.170 |
Why?
|
| Autophagy | 3 | 2012 | 1327 | 0.170 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 6 | 2014 | 2872 | 0.170 |
Why?
|
| Oligopeptides | 5 | 2012 | 1187 | 0.170 |
Why?
|
| Fluorides | 2 | 2000 | 134 | 0.170 |
Why?
|
| Blood Cells | 1 | 2021 | 305 | 0.170 |
Why?
|
| Indoles | 3 | 2012 | 1833 | 0.170 |
Why?
|
| Life | 2 | 2012 | 13 | 0.170 |
Why?
|
| Fungal Proteins | 4 | 2001 | 910 | 0.170 |
Why?
|
| Economics | 2 | 2011 | 141 | 0.170 |
Why?
|
| Subtilisins | 3 | 2003 | 81 | 0.160 |
Why?
|
| Proteome | 4 | 2002 | 1862 | 0.160 |
Why?
|
| Gene Expression Regulation, Bacterial | 2 | 2017 | 1133 | 0.160 |
Why?
|
| Pedigree | 2 | 2024 | 4542 | 0.160 |
Why?
|
| Geobacillus stearothermophilus | 4 | 2000 | 24 | 0.160 |
Why?
|
| Telomerase | 1 | 2024 | 745 | 0.160 |
Why?
|
| Macromolecular Substances | 11 | 2002 | 1434 | 0.160 |
Why?
|
| Binding, Competitive | 6 | 2009 | 1141 | 0.160 |
Why?
|
| NAD | 6 | 2004 | 614 | 0.160 |
Why?
|
| Calcium-Binding Proteins | 5 | 1985 | 1069 | 0.160 |
Why?
|
| Spinal Injuries | 1 | 2022 | 301 | 0.160 |
Why?
|
| Solubility | 1 | 2020 | 1091 | 0.160 |
Why?
|
| Directed Molecular Evolution | 1 | 2000 | 162 | 0.160 |
Why?
|
| Sorting Nexins | 1 | 2018 | 27 | 0.160 |
Why?
|
| Investments | 2 | 2010 | 147 | 0.160 |
Why?
|
| Philosophy | 2 | 2010 | 68 | 0.160 |
Why?
|
| Colonoscopy | 1 | 2007 | 1394 | 0.160 |
Why?
|
| Cystathionine beta-Synthase | 1 | 2018 | 27 | 0.160 |
Why?
|
| 3-Isopropylmalate Dehydrogenase | 5 | 1998 | 5 | 0.150 |
Why?
|
| Chemical Phenomena | 9 | 1993 | 507 | 0.150 |
Why?
|
| Alanine Racemase | 3 | 1999 | 5 | 0.150 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 1 | 2024 | 515 | 0.150 |
Why?
|
| Medicago | 1 | 2018 | 4 | 0.150 |
Why?
|
| Publications | 1 | 2000 | 194 | 0.150 |
Why?
|
| Editorial Policies | 1 | 2003 | 458 | 0.150 |
Why?
|
| Animals, Domestic | 2 | 2009 | 56 | 0.150 |
Why?
|
| Oxidation-Reduction | 9 | 2018 | 2231 | 0.150 |
Why?
|
| Piperidines | 1 | 2006 | 1656 | 0.150 |
Why?
|
| Thiamine Pyrophosphate | 4 | 2009 | 8 | 0.150 |
Why?
|
| Substantia Nigra | 2 | 2018 | 350 | 0.150 |
Why?
|
| Teaching | 1 | 2006 | 1170 | 0.150 |
Why?
|
| IMP Dehydrogenase | 3 | 2003 | 33 | 0.150 |
Why?
|
| Boron Compounds | 1 | 1999 | 182 | 0.150 |
Why?
|
| Endopeptidases | 3 | 2003 | 774 | 0.150 |
Why?
|
| Zinc | 7 | 2008 | 690 | 0.150 |
Why?
|
| Mass Spectrometry | 4 | 2014 | 2192 | 0.140 |
Why?
|
| Metmyoglobin | 7 | 1987 | 7 | 0.140 |
Why?
|
| Apolipoprotein E2 | 1 | 2018 | 135 | 0.140 |
Why?
|
| RNA Helicases | 3 | 2015 | 144 | 0.140 |
Why?
|
| Activities of Daily Living | 1 | 2007 | 2421 | 0.140 |
Why?
|
| Microscopy | 1 | 2022 | 903 | 0.140 |
Why?
|
| Travel | 1 | 2003 | 796 | 0.140 |
Why?
|
| Hemoglobins | 2 | 2002 | 1526 | 0.140 |
Why?
|
| Thinking | 1 | 2000 | 320 | 0.140 |
Why?
|
| Protons | 7 | 2013 | 1116 | 0.140 |
Why?
|
| Hydrolysis | 7 | 2006 | 664 | 0.140 |
Why?
|
| Vibrio | 1 | 1997 | 40 | 0.140 |
Why?
|
| Hydrolases | 2 | 2013 | 147 | 0.140 |
Why?
|
| Interleukin-1beta | 2 | 2020 | 999 | 0.140 |
Why?
|
| Aldehyde Oxidoreductases | 1 | 2017 | 88 | 0.140 |
Why?
|
| Monosaccharide Transport Proteins | 3 | 1983 | 436 | 0.140 |
Why?
|
| Metalloproteins | 1 | 2017 | 101 | 0.140 |
Why?
|
| Metals | 2 | 2016 | 719 | 0.140 |
Why?
|
| Serine | 4 | 2008 | 831 | 0.140 |
Why?
|
| Genes, Reporter | 1 | 2020 | 1529 | 0.140 |
Why?
|
| Magnetic Resonance Spectroscopy | 11 | 2021 | 3769 | 0.140 |
Why?
|
| Enzyme Activation | 5 | 2009 | 3597 | 0.140 |
Why?
|
| Inverted Repeat Sequences | 1 | 2016 | 60 | 0.140 |
Why?
|
| Mutant Proteins | 1 | 2018 | 491 | 0.130 |
Why?
|
| Small Molecule Libraries | 2 | 2014 | 733 | 0.130 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2020 | 2467 | 0.130 |
Why?
|
| Triazines | 1 | 2018 | 311 | 0.130 |
Why?
|
| Computer Simulation | 12 | 2008 | 6241 | 0.130 |
Why?
|
| Static Electricity | 8 | 2014 | 261 | 0.130 |
Why?
|
| Lewy Bodies | 1 | 2016 | 145 | 0.130 |
Why?
|
| Protein Engineering | 2 | 2010 | 549 | 0.130 |
Why?
|
| Cholera Toxin | 1 | 2018 | 559 | 0.130 |
Why?
|
| Christianity | 2 | 2009 | 50 | 0.130 |
Why?
|
| Glucose | 5 | 2004 | 4347 | 0.130 |
Why?
|
| Decision Making | 1 | 2009 | 3929 | 0.130 |
Why?
|
| Genetics, Population | 2 | 2012 | 937 | 0.130 |
Why?
|
| Antigen-Antibody Complex | 3 | 2004 | 510 | 0.130 |
Why?
|
| Iraq | 2 | 2007 | 92 | 0.130 |
Why?
|
| Carrier Proteins | 5 | 2014 | 4937 | 0.130 |
Why?
|
| Lysine | 6 | 1999 | 993 | 0.130 |
Why?
|
| Chemistry, Pharmaceutical | 1 | 1996 | 274 | 0.130 |
Why?
|
| Metals, Heavy | 1 | 2017 | 148 | 0.130 |
Why?
|
| Tromethamine | 2 | 2007 | 31 | 0.120 |
Why?
|
| Histidine | 9 | 2011 | 308 | 0.120 |
Why?
|
| Cattle | 7 | 2011 | 3849 | 0.120 |
Why?
|
| DNA Adducts | 1 | 1995 | 94 | 0.120 |
Why?
|
| Recombinant Fusion Proteins | 5 | 2017 | 3733 | 0.120 |
Why?
|
| Biological Science Disciplines | 2 | 2008 | 57 | 0.120 |
Why?
|
| Internet | 4 | 2009 | 3093 | 0.120 |
Why?
|
| Fetus | 1 | 2022 | 1863 | 0.120 |
Why?
|
| Isomerism | 2 | 1992 | 197 | 0.120 |
Why?
|
| Multiple System Atrophy | 1 | 2016 | 130 | 0.120 |
Why?
|
| Aspartate-Semialdehyde Dehydrogenase | 3 | 2001 | 4 | 0.120 |
Why?
|
| Peptides | 6 | 2013 | 4358 | 0.120 |
Why?
|
| Colonic Neoplasms | 1 | 2007 | 2539 | 0.120 |
Why?
|
| Forelimb | 1 | 2014 | 116 | 0.120 |
Why?
|
| Mycobacterium tuberculosis | 2 | 2017 | 1914 | 0.120 |
Why?
|
| Algorithms | 3 | 2006 | 14033 | 0.120 |
Why?
|
| Spinal Cord Injuries | 1 | 2022 | 925 | 0.120 |
Why?
|
| Apolipoproteins E | 1 | 2020 | 1443 | 0.120 |
Why?
|
| Ribonucleases | 5 | 1990 | 277 | 0.120 |
Why?
|
| Enhancer Elements, Genetic | 2 | 2016 | 1363 | 0.120 |
Why?
|
| Peptide Elongation Factor Tu | 1 | 1994 | 19 | 0.120 |
Why?
|
| Naegleria | 1 | 2013 | 1 | 0.120 |
Why?
|
| DNA-Binding Proteins | 7 | 2014 | 9610 | 0.120 |
Why?
|
| Aminopyridines | 1 | 2018 | 573 | 0.120 |
Why?
|
| Nobel Prize | 2 | 2006 | 48 | 0.120 |
Why?
|
| Interprofessional Relations | 1 | 2000 | 990 | 0.120 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2016 | 452 | 0.120 |
Why?
|
| Genome, Bacterial | 2 | 2010 | 783 | 0.120 |
Why?
|
| Chaperonin 60 | 1 | 2014 | 97 | 0.110 |
Why?
|
| Phenylpropionates | 1 | 1994 | 35 | 0.110 |
Why?
|
| Software | 5 | 2006 | 4434 | 0.110 |
Why?
|
| Tetrahydrofolate Dehydrogenase | 1 | 2014 | 133 | 0.110 |
Why?
|
| Ketosteroids | 1 | 2013 | 3 | 0.110 |
Why?
|
| Glutamates | 2 | 1994 | 389 | 0.110 |
Why?
|
| Cinnamates | 2 | 1990 | 59 | 0.110 |
Why?
|
| Genetic Engineering | 4 | 2004 | 933 | 0.110 |
Why?
|
| Homoserine | 1 | 2013 | 12 | 0.110 |
Why?
|
| Attitude | 2 | 2008 | 775 | 0.110 |
Why?
|
| Culture | 2 | 2010 | 623 | 0.110 |
Why?
|
| Oxygen | 7 | 2013 | 4227 | 0.110 |
Why?
|
| Microscopy, Fluorescence | 1 | 2020 | 2645 | 0.110 |
Why?
|
| Neutron Diffraction | 2 | 2011 | 10 | 0.110 |
Why?
|
| Diet | 1 | 2011 | 8075 | 0.110 |
Why?
|
| gamma-Aminobutyric Acid | 2 | 2017 | 1141 | 0.110 |
Why?
|
| Proprotein Convertases | 2 | 2004 | 95 | 0.110 |
Why?
|
| Hemeproteins | 4 | 1987 | 61 | 0.110 |
Why?
|
| Cell Cycle Proteins | 1 | 2024 | 3449 | 0.100 |
Why?
|
| NF-kappa B | 1 | 2021 | 2490 | 0.100 |
Why?
|
| Oncogene Protein pp60(v-src) | 1 | 1992 | 75 | 0.100 |
Why?
|
| Butyrates | 2 | 2009 | 169 | 0.100 |
Why?
|
| Guanosine Triphosphate | 2 | 1990 | 316 | 0.100 |
Why?
|
| Base Sequence | 16 | 1996 | 12441 | 0.100 |
Why?
|
| Amino Acid Chloromethyl Ketones | 1 | 2012 | 68 | 0.100 |
Why?
|
| Xenopus laevis | 1 | 2016 | 963 | 0.100 |
Why?
|
| Aldehyde Reductase | 4 | 1997 | 71 | 0.100 |
Why?
|
| Oligodendroglia | 1 | 2016 | 538 | 0.100 |
Why?
|
| Phosphorylation | 3 | 2018 | 8321 | 0.100 |
Why?
|
| HIV Protease | 1 | 1992 | 97 | 0.100 |
Why?
|
| Chlamydia trachomatis | 1 | 1994 | 239 | 0.100 |
Why?
|
| Amidohydrolases | 1 | 2013 | 159 | 0.100 |
Why?
|
| Government Regulation | 2 | 2009 | 524 | 0.100 |
Why?
|
| Genes, Bacterial | 3 | 1998 | 1073 | 0.100 |
Why?
|
| Cloning, Molecular | 10 | 2007 | 4174 | 0.100 |
Why?
|
| Isocitrate Dehydrogenase | 1 | 2018 | 938 | 0.100 |
Why?
|
| Intracellular Fluid | 1 | 2012 | 201 | 0.100 |
Why?
|
| Religious Philosophies | 1 | 2011 | 3 | 0.100 |
Why?
|
| Brain Diseases | 1 | 2020 | 1546 | 0.100 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 3 | 2009 | 3779 | 0.100 |
Why?
|
| Proteostasis Deficiencies | 1 | 2011 | 39 | 0.100 |
Why?
|
| Glutamic Acid | 6 | 2011 | 1176 | 0.100 |
Why?
|
| Stem Cells | 1 | 2004 | 3524 | 0.100 |
Why?
|
| Guidelines as Topic | 2 | 2012 | 1386 | 0.090 |
Why?
|
| Databases, Protein | 2 | 2011 | 387 | 0.090 |
Why?
|
| Methionine | 2 | 2017 | 572 | 0.090 |
Why?
|
| Inflammasomes | 1 | 2016 | 526 | 0.090 |
Why?
|
| NADH, NADPH Oxidoreductases | 1 | 1991 | 94 | 0.090 |
Why?
|
| September 11 Terrorist Attacks | 1 | 2012 | 105 | 0.090 |
Why?
|
| Receptors, Virus | 1 | 2014 | 640 | 0.090 |
Why?
|
| tau Proteins | 2 | 2020 | 2095 | 0.090 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2013 | 615 | 0.090 |
Why?
|
| Gene Expression Regulation | 6 | 2024 | 11904 | 0.090 |
Why?
|
| Azides | 1 | 1990 | 118 | 0.090 |
Why?
|
| Chemotaxis | 1 | 1993 | 598 | 0.090 |
Why?
|
| Glycolates | 1 | 1990 | 40 | 0.090 |
Why?
|
| Central Nervous System | 1 | 2018 | 1336 | 0.090 |
Why?
|
| Jurisprudence | 1 | 2010 | 109 | 0.090 |
Why?
|
| Botany | 1 | 2010 | 4 | 0.090 |
Why?
|
| Snake Venoms | 4 | 1977 | 38 | 0.090 |
Why?
|
| RNA | 1 | 2000 | 2725 | 0.090 |
Why?
|
| Contig Mapping | 1 | 2010 | 54 | 0.090 |
Why?
|
| Models, Genetic | 1 | 2000 | 3442 | 0.090 |
Why?
|
| Professional Review Organizations | 1 | 2009 | 48 | 0.090 |
Why?
|
| Journal Impact Factor | 1 | 2011 | 153 | 0.090 |
Why?
|
| PTEN Phosphohydrolase | 2 | 2014 | 1115 | 0.090 |
Why?
|
| Breeding | 1 | 2009 | 51 | 0.090 |
Why?
|
| Corpus Striatum | 1 | 2016 | 1235 | 0.090 |
Why?
|
| Polyamines | 1 | 2010 | 133 | 0.090 |
Why?
|
| beta-Glucosidase | 1 | 2009 | 10 | 0.080 |
Why?
|
| Genealogy and Heraldry | 1 | 2009 | 29 | 0.080 |
Why?
|
| Spectrophotometry, Ultraviolet | 4 | 2004 | 201 | 0.080 |
Why?
|
| Nuclear Proteins | 1 | 2024 | 5799 | 0.080 |
Why?
|
| Arsenicals | 1 | 1990 | 118 | 0.080 |
Why?
|
| Peptide Fragments | 7 | 2017 | 5112 | 0.080 |
Why?
|
| Artificial Intelligence | 1 | 2004 | 2578 | 0.080 |
Why?
|
| Haplotypes | 2 | 2021 | 2713 | 0.080 |
Why?
|
| Acetyltransferases | 1 | 2010 | 231 | 0.080 |
Why?
|
| Pensions | 1 | 2009 | 16 | 0.080 |
Why?
|
| Statistics as Topic | 2 | 2006 | 2358 | 0.080 |
Why?
|
| T-Lymphocytes | 2 | 2018 | 10194 | 0.080 |
Why?
|
| Pigmentation | 1 | 2009 | 144 | 0.080 |
Why?
|
| Disasters | 2 | 2005 | 519 | 0.080 |
Why?
|
| Selection, Genetic | 2 | 2006 | 868 | 0.080 |
Why?
|
| Serine Endopeptidases | 1 | 2014 | 1023 | 0.080 |
Why?
|
| Models, Biological | 7 | 2015 | 9469 | 0.080 |
Why?
|
| Mandelic Acids | 6 | 1996 | 46 | 0.080 |
Why?
|
| Heterozygote | 2 | 2020 | 2787 | 0.080 |
Why?
|
| Amino Acid Substitution | 5 | 2017 | 1739 | 0.080 |
Why?
|
| Platinum | 2 | 2001 | 220 | 0.080 |
Why?
|
| Cells, Cultured | 7 | 2021 | 18966 | 0.080 |
Why?
|
| Adult Stem Cells | 1 | 2010 | 221 | 0.080 |
Why?
|
| Bacillus | 2 | 1995 | 78 | 0.080 |
Why?
|
| Wit and Humor as Topic | 1 | 2008 | 31 | 0.080 |
Why?
|
| Promoter Regions, Genetic | 2 | 2017 | 5790 | 0.080 |
Why?
|
| Virtues | 1 | 2008 | 9 | 0.080 |
Why?
|
| Private Sector | 1 | 2011 | 398 | 0.080 |
Why?
|
| Amino Acid Isomerases | 1 | 1987 | 31 | 0.080 |
Why?
|
| New York | 1 | 2010 | 874 | 0.080 |
Why?
|
| Fluorometry | 2 | 2021 | 99 | 0.070 |
Why?
|
| Hemochromatosis | 1 | 2009 | 174 | 0.070 |
Why?
|
| Osteoblasts | 1 | 2013 | 1143 | 0.070 |
Why?
|
| Muscle Contraction | 1 | 2012 | 1201 | 0.070 |
Why?
|
| Cytoskeleton | 1 | 2012 | 1170 | 0.070 |
Why?
|
| National Institute of General Medical Sciences (U.S.) | 1 | 2007 | 2 | 0.070 |
Why?
|
| Geological Phenomena | 1 | 2007 | 11 | 0.070 |
Why?
|
| Adenylate Kinase | 1 | 2007 | 102 | 0.070 |
Why?
|
| Cell Compartmentation | 2 | 2001 | 384 | 0.070 |
Why?
|
| Museums | 1 | 2007 | 20 | 0.070 |
Why?
|
| Behavior, Animal | 1 | 2015 | 1878 | 0.070 |
Why?
|
| Central Nervous System Diseases | 1 | 2011 | 520 | 0.070 |
Why?
|
| Social Values | 1 | 2008 | 225 | 0.070 |
Why?
|
| Signal Transduction | 10 | 2020 | 23447 | 0.070 |
Why?
|
| Cobalt | 1 | 2007 | 154 | 0.070 |
Why?
|
| Iron | 4 | 1998 | 1793 | 0.070 |
Why?
|
| Carbon-Carbon Double Bond Isomerases | 1 | 2006 | 5 | 0.070 |
Why?
|
| Tritrichomonas foetus | 2 | 2003 | 2 | 0.070 |
Why?
|
| Systems Biology | 1 | 2010 | 481 | 0.070 |
Why?
|
| Viral Proteins | 2 | 1991 | 1804 | 0.070 |
Why?
|
| DNA Primers | 4 | 1994 | 2820 | 0.070 |
Why?
|
| Cytoplasm | 1 | 2011 | 1510 | 0.070 |
Why?
|
| Food | 1 | 2011 | 774 | 0.070 |
Why?
|
| Leukemia, Myeloid, Acute | 2 | 2021 | 3615 | 0.070 |
Why?
|
| Croatia | 1 | 2006 | 34 | 0.070 |
Why?
|
| Authorship | 1 | 2009 | 284 | 0.070 |
Why?
|
| Azetidinecarboxylic Acid | 2 | 2002 | 4 | 0.070 |
Why?
|
| Russia | 1 | 2007 | 384 | 0.070 |
Why?
|
| Laboratories | 1 | 2010 | 458 | 0.070 |
Why?
|
| Aeromonas hydrophila | 1 | 2005 | 10 | 0.070 |
Why?
|
| Hair | 1 | 2009 | 498 | 0.070 |
Why?
|
| Models, Structural | 6 | 1997 | 340 | 0.070 |
Why?
|
| Antineoplastic Agents | 2 | 2001 | 13642 | 0.060 |
Why?
|
| Genetic Variation | 3 | 2010 | 6567 | 0.060 |
Why?
|
| Fossils | 1 | 2006 | 75 | 0.060 |
Why?
|
| United States National Aeronautics and Space Administration | 1 | 2005 | 15 | 0.060 |
Why?
|
| Extraterrestrial Environment | 1 | 2005 | 25 | 0.060 |
Why?
|
| World Health Organization | 1 | 2012 | 1322 | 0.060 |
Why?
|
| Corynebacterium diphtheriae | 2 | 1995 | 21 | 0.060 |
Why?
|
| Living Wills | 1 | 2005 | 19 | 0.060 |
Why?
|
| Nitric Oxide | 1 | 2014 | 2136 | 0.060 |
Why?
|
| Mice, Transgenic | 5 | 2020 | 9542 | 0.060 |
Why?
|
| Demography | 1 | 2010 | 1648 | 0.060 |
Why?
|
| Tennessee | 1 | 2005 | 120 | 0.060 |
Why?
|
| Immune Tolerance | 1 | 2014 | 2302 | 0.060 |
Why?
|
| Functional Laterality | 1 | 1992 | 2257 | 0.060 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 3 | 2012 | 506 | 0.060 |
Why?
|
| Right to Die | 1 | 2005 | 34 | 0.060 |
Why?
|
| Chromosomes, Mammalian | 1 | 2006 | 147 | 0.060 |
Why?
|
| Electron Spin Resonance Spectroscopy | 2 | 2004 | 162 | 0.060 |
Why?
|
| Epilepsy | 1 | 2020 | 3290 | 0.060 |
Why?
|
| Brain Stem | 1 | 2010 | 858 | 0.060 |
Why?
|
| Fibroblasts | 2 | 2024 | 4142 | 0.060 |
Why?
|
| Birds | 1 | 2005 | 168 | 0.060 |
Why?
|
| Heme | 5 | 2018 | 313 | 0.060 |
Why?
|
| Reproducibility of Results | 4 | 2010 | 20100 | 0.060 |
Why?
|
| Peptide Hydrolases | 2 | 2003 | 624 | 0.060 |
Why?
|
| Blood Proteins | 1 | 1990 | 1173 | 0.060 |
Why?
|
| World War II | 1 | 2005 | 61 | 0.060 |
Why?
|
| Molecular Conformation | 6 | 2000 | 544 | 0.060 |
Why?
|
| Disease Models, Animal | 5 | 2020 | 18255 | 0.060 |
Why?
|
| Antibodies, Monoclonal | 6 | 2004 | 9177 | 0.060 |
Why?
|
| Models, Animal | 1 | 2011 | 2112 | 0.060 |
Why?
|
| Bibliometrics | 1 | 2008 | 352 | 0.060 |
Why?
|
| Adaptation, Biological | 1 | 2005 | 147 | 0.060 |
Why?
|
| Astronauts | 1 | 2005 | 92 | 0.060 |
Why?
|
| Pharmacology, Clinical | 1 | 2004 | 22 | 0.060 |
Why?
|
| Paintings | 1 | 2006 | 103 | 0.060 |
Why?
|
| UDPglucose 4-Epimerase | 1 | 2004 | 14 | 0.060 |
Why?
|
| Homozygote | 1 | 2009 | 1776 | 0.060 |
Why?
|
| Fumarate Hydratase | 1 | 2004 | 52 | 0.060 |
Why?
|
| Therapeutics | 1 | 2004 | 113 | 0.060 |
Why?
|
| Polymers | 1 | 2011 | 1616 | 0.060 |
Why?
|
| Alanine Transaminase | 2 | 1998 | 603 | 0.060 |
Why?
|
| Xenon | 1 | 1984 | 112 | 0.060 |
Why?
|
| Furin | 1 | 2004 | 46 | 0.060 |
Why?
|
| Perception | 1 | 2010 | 1197 | 0.060 |
Why?
|
| Protein Processing, Post-Translational | 4 | 2014 | 1974 | 0.060 |
Why?
|
| Carbon Disulfide | 1 | 1983 | 5 | 0.060 |
Why?
|
| Geography | 1 | 2006 | 656 | 0.060 |
Why?
|
| Hydrogen | 1 | 2004 | 172 | 0.060 |
Why?
|
| Health Services | 1 | 2009 | 752 | 0.060 |
Why?
|
| China | 1 | 2010 | 2374 | 0.060 |
Why?
|
| Climate Change | 1 | 2010 | 501 | 0.060 |
Why?
|
| Sequence Homology | 2 | 2001 | 196 | 0.050 |
Why?
|
| Germany | 1 | 2006 | 875 | 0.050 |
Why?
|
| Mutation, Missense | 3 | 2024 | 2571 | 0.050 |
Why?
|
| Spectroscopy, Fourier Transform Infrared | 3 | 1998 | 161 | 0.050 |
Why?
|
| Conserved Sequence | 3 | 2002 | 1163 | 0.050 |
Why?
|
| Embryonic Stem Cells | 1 | 2010 | 1263 | 0.050 |
Why?
|
| Transcription, Genetic | 4 | 2021 | 7593 | 0.050 |
Why?
|
| Short Interspersed Nucleotide Elements | 1 | 2003 | 41 | 0.050 |
Why?
|
| Haptens | 3 | 1993 | 163 | 0.050 |
Why?
|
| Biocatalysis | 2 | 2017 | 170 | 0.050 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2018 | 5305 | 0.050 |
Why?
|
| Light | 2 | 2022 | 1353 | 0.050 |
Why?
|
| Photolysis | 3 | 1997 | 94 | 0.050 |
Why?
|
| Thiophenes | 1 | 2007 | 569 | 0.050 |
Why?
|
| Fellowships and Scholarships | 1 | 2012 | 1117 | 0.050 |
Why?
|
| Myelodysplastic Syndromes | 2 | 2024 | 1394 | 0.050 |
Why?
|
| Terminal Repeat Sequences | 1 | 2003 | 70 | 0.050 |
Why?
|
| Ribonucleosides | 1 | 2003 | 79 | 0.050 |
Why?
|
| Sweden | 1 | 2006 | 1379 | 0.050 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2009 | 1349 | 0.050 |
Why?
|
| Motion | 4 | 2007 | 779 | 0.050 |
Why?
|
| Chromatography, Gel | 1 | 2003 | 646 | 0.050 |
Why?
|
| Writing | 1 | 2004 | 199 | 0.050 |
Why?
|
| Rats | 4 | 2020 | 23741 | 0.050 |
Why?
|
| Guanosine Diphosphate | 2 | 1994 | 80 | 0.050 |
Why?
|
| Structural Homology, Protein | 2 | 2017 | 87 | 0.050 |
Why?
|
| Boronic Acids | 2 | 2004 | 915 | 0.050 |
Why?
|
| Texas | 1 | 2003 | 404 | 0.050 |
Why?
|
| Hydrogen Peroxide | 2 | 2013 | 730 | 0.050 |
Why?
|
| Whales | 4 | 1988 | 30 | 0.050 |
Why?
|
| Galactose | 1 | 1983 | 297 | 0.050 |
Why?
|
| Proline | 3 | 2001 | 457 | 0.050 |
Why?
|
| DNA, Recombinant | 1 | 2002 | 455 | 0.050 |
Why?
|
| Cell Nucleus | 1 | 2011 | 2910 | 0.050 |
Why?
|
| Calmodulin | 1 | 1983 | 218 | 0.050 |
Why?
|
| Brain | 6 | 2022 | 27121 | 0.050 |
Why?
|
| Genes, Plant | 1 | 2002 | 128 | 0.050 |
Why?
|
| Hydroxamic Acids | 3 | 1996 | 481 | 0.050 |
Why?
|
| Parkinsonian Disorders | 1 | 2005 | 284 | 0.050 |
Why?
|
| Base Pairing | 1 | 2002 | 140 | 0.050 |
Why?
|
| History, Medieval | 1 | 2001 | 62 | 0.050 |
Why?
|
| Amyloid Precursor Protein Secretases | 2 | 2018 | 620 | 0.050 |
Why?
|
| Myelin Sheath | 1 | 2006 | 653 | 0.050 |
Why?
|
| Spectrophotometry | 2 | 1999 | 309 | 0.050 |
Why?
|
| Adenosine Diphosphate | 1 | 2002 | 422 | 0.050 |
Why?
|
| p-Azobenzenearsonate | 2 | 1991 | 41 | 0.050 |
Why?
|
| Amino Acid Motifs | 2 | 2014 | 931 | 0.050 |
Why?
|
| Heat-Shock Response | 1 | 2002 | 179 | 0.050 |
Why?
|
| Obesity | 1 | 2003 | 12947 | 0.050 |
Why?
|
| Genetic Association Studies | 1 | 2010 | 2735 | 0.050 |
Why?
|
| Swine | 6 | 2006 | 5915 | 0.050 |
Why?
|
| Pliability | 2 | 2000 | 59 | 0.050 |
Why?
|
| Munc18 Proteins | 1 | 2020 | 20 | 0.050 |
Why?
|
| Schiff Bases | 2 | 2017 | 22 | 0.050 |
Why?
|
| Mutagenesis | 3 | 2000 | 1232 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 5 | 2020 | 22174 | 0.050 |
Why?
|
| Pregnancy | 2 | 2022 | 29890 | 0.050 |
Why?
|
| Myelopoiesis | 1 | 2021 | 134 | 0.050 |
Why?
|
| Proto-Oncogene Proteins | 2 | 1990 | 4514 | 0.050 |
Why?
|
| Cystic Fibrosis | 1 | 1990 | 1285 | 0.050 |
Why?
|
| Long Interspersed Nucleotide Elements | 1 | 2003 | 330 | 0.050 |
Why?
|
| Entropy | 1 | 2001 | 210 | 0.050 |
Why?
|
| Turkey | 1 | 2021 | 254 | 0.050 |
Why?
|
| Genes, Recessive | 1 | 2003 | 623 | 0.040 |
Why?
|
| Lipopolysaccharides | 2 | 2020 | 2206 | 0.040 |
Why?
|
| England | 1 | 2002 | 526 | 0.040 |
Why?
|
| Camphor 5-Monooxygenase | 1 | 2000 | 2 | 0.040 |
Why?
|
| D-Alanine Transaminase | 5 | 1998 | 6 | 0.040 |
Why?
|
| Camphor | 1 | 2000 | 9 | 0.040 |
Why?
|
| Salts | 2 | 1998 | 63 | 0.040 |
Why?
|
| Indole-3-Glycerol-Phosphate Synthase | 1 | 2000 | 3 | 0.040 |
Why?
|
| Human Rights | 1 | 2003 | 309 | 0.040 |
Why?
|
| Female | 14 | 2024 | 392705 | 0.040 |
Why?
|
| Carbohydrates | 1 | 2022 | 390 | 0.040 |
Why?
|
| Glutamine | 2 | 2018 | 577 | 0.040 |
Why?
|
| Heart Failure | 1 | 2004 | 11671 | 0.040 |
Why?
|
| Disulfides | 2 | 2014 | 465 | 0.040 |
Why?
|
| Cell Line, Tumor | 4 | 2021 | 16990 | 0.040 |
Why?
|
| Spinal Cord | 2 | 2022 | 1819 | 0.040 |
Why?
|
| Transcription Factors | 3 | 2021 | 12130 | 0.040 |
Why?
|
| Borrelia burgdorferi Group | 1 | 2000 | 97 | 0.040 |
Why?
|
| Chickens | 9 | 1999 | 859 | 0.040 |
Why?
|
| K562 Cells | 1 | 2021 | 642 | 0.040 |
Why?
|
| Egg White | 3 | 1992 | 16 | 0.040 |
Why?
|
| Anions | 3 | 2008 | 136 | 0.040 |
Why?
|
| Cross Reactions | 2 | 1994 | 817 | 0.040 |
Why?
|
| Heterochromatin | 1 | 2002 | 293 | 0.040 |
Why?
|
| Leucyl Aminopeptidase | 1 | 1999 | 12 | 0.040 |
Why?
|
| Clinical Trials as Topic | 2 | 2016 | 8002 | 0.040 |
Why?
|
| Luminescent Proteins | 1 | 2022 | 837 | 0.040 |
Why?
|
| Cocaine | 1 | 2005 | 958 | 0.040 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 3 | 2012 | 1741 | 0.040 |
Why?
|
| Open Reading Frames | 2 | 2001 | 815 | 0.040 |
Why?
|
| Morphine | 1 | 2004 | 657 | 0.040 |
Why?
|
| Phosphatidylinositols | 1 | 2000 | 282 | 0.040 |
Why?
|
| Ciprofloxacin | 1 | 2001 | 312 | 0.040 |
Why?
|
| RNA Editing | 1 | 2001 | 151 | 0.040 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2009 | 15936 | 0.040 |
Why?
|
| Plant Proteins | 1 | 2002 | 370 | 0.040 |
Why?
|
| Protease Inhibitors | 1 | 2003 | 754 | 0.040 |
Why?
|
| Genetic Testing | 1 | 2012 | 3537 | 0.040 |
Why?
|
| Genome, Viral | 1 | 2003 | 667 | 0.040 |
Why?
|
| Chromosomes | 1 | 2002 | 578 | 0.040 |
Why?
|
| Social Behavior | 1 | 2006 | 1135 | 0.040 |
Why?
|
| Sequence Analysis | 2 | 1997 | 240 | 0.040 |
Why?
|
| Macrophages | 1 | 2014 | 5767 | 0.040 |
Why?
|
| Putamen | 1 | 2020 | 292 | 0.040 |
Why?
|
| Risk | 1 | 2011 | 9610 | 0.040 |
Why?
|
| Melanoma | 1 | 2018 | 5709 | 0.040 |
Why?
|
| Hemagglutinins | 1 | 1999 | 113 | 0.040 |
Why?
|
| History, 19th Century | 1 | 2001 | 720 | 0.040 |
Why?
|
| Operon | 2 | 2017 | 372 | 0.040 |
Why?
|
| Cell Differentiation | 3 | 2021 | 11530 | 0.040 |
Why?
|
| Tanzania | 1 | 2003 | 1390 | 0.040 |
Why?
|
| Carboxylic Acids | 1 | 1999 | 90 | 0.040 |
Why?
|
| Tyrosine | 2 | 1994 | 1440 | 0.040 |
Why?
|
| Deuterium Oxide | 1 | 1998 | 34 | 0.040 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2000 | 412 | 0.040 |
Why?
|
| Cell Survival | 3 | 2016 | 5791 | 0.040 |
Why?
|
| Mice, Inbred BALB C | 2 | 2020 | 6214 | 0.040 |
Why?
|
| Cell Line | 3 | 2014 | 15601 | 0.040 |
Why?
|
| Costs and Cost Analysis | 1 | 2004 | 1668 | 0.040 |
Why?
|
| Genes, Fungal | 3 | 2004 | 439 | 0.040 |
Why?
|
| Oxidative Stress | 3 | 2005 | 3113 | 0.040 |
Why?
|
| Drug Combinations | 1 | 2004 | 2048 | 0.040 |
Why?
|
| Calorimetry, Differential Scanning | 1 | 1998 | 100 | 0.040 |
Why?
|
| Apoptosis | 1 | 2014 | 9490 | 0.040 |
Why?
|
| Isoleucine | 1 | 2018 | 110 | 0.040 |
Why?
|
| Ataxia | 1 | 2020 | 306 | 0.040 |
Why?
|
| Solutions | 3 | 2007 | 412 | 0.040 |
Why?
|
| Employment | 1 | 2005 | 1118 | 0.040 |
Why?
|
| Propionates | 1 | 1999 | 183 | 0.040 |
Why?
|
| Anisotropy | 1 | 2002 | 1283 | 0.040 |
Why?
|
| Phosphopyruvate Hydratase | 1 | 1998 | 127 | 0.040 |
Why?
|
| Allosteric Site | 1 | 2018 | 103 | 0.040 |
Why?
|
| Digoxin | 2 | 1993 | 246 | 0.040 |
Why?
|
| Skin Neoplasms | 1 | 2018 | 5821 | 0.040 |
Why?
|
| Down-Regulation | 2 | 2018 | 2919 | 0.040 |
Why?
|
| Cross-Linking Reagents | 2 | 2012 | 687 | 0.040 |
Why?
|
| Telomere | 1 | 2024 | 943 | 0.040 |
Why?
|
| Protein Kinases | 1 | 2005 | 1608 | 0.040 |
Why?
|
| Erythropoiesis | 1 | 2021 | 683 | 0.040 |
Why?
|
| Drug Delivery Systems | 1 | 2009 | 2226 | 0.040 |
Why?
|
| Caco-2 Cells | 1 | 2018 | 364 | 0.040 |
Why?
|
| Arctic Regions | 1 | 1997 | 26 | 0.040 |
Why?
|
| Growth Substances | 1 | 2000 | 768 | 0.040 |
Why?
|
| RNA, Messenger | 2 | 2011 | 12794 | 0.040 |
Why?
|
| Selenomethionine | 1 | 2017 | 18 | 0.040 |
Why?
|
| Organ Specificity | 1 | 2002 | 1968 | 0.040 |
Why?
|
| Pentanoic Acids | 1 | 2017 | 17 | 0.040 |
Why?
|
| Tryptophan | 2 | 1998 | 482 | 0.040 |
Why?
|
| Multienzyme Complexes | 1 | 2001 | 666 | 0.040 |
Why?
|
| Botulinum Toxins | 1 | 1999 | 189 | 0.040 |
Why?
|
| Porphyromonas gingivalis | 1 | 1998 | 164 | 0.040 |
Why?
|
| Basal Ganglia | 1 | 2020 | 554 | 0.040 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2001 | 790 | 0.040 |
Why?
|
| Lens, Crystalline | 1 | 1999 | 389 | 0.040 |
Why?
|
| Citrates | 2 | 1994 | 134 | 0.040 |
Why?
|
| Male | 11 | 2024 | 360846 | 0.040 |
Why?
|
| Marine Toxins | 1 | 1976 | 24 | 0.030 |
Why?
|
| UTP-Hexose-1-Phosphate Uridylyltransferase | 1 | 1997 | 68 | 0.030 |
Why?
|
| Nigericin | 1 | 2016 | 10 | 0.030 |
Why?
|
| Rabbits | 3 | 2000 | 4772 | 0.030 |
Why?
|
| Pyridines | 1 | 2009 | 2875 | 0.030 |
Why?
|
| International Cooperation | 1 | 2003 | 1422 | 0.030 |
Why?
|
| Vitamin K 3 | 1 | 2016 | 14 | 0.030 |
Why?
|
| Alum Compounds | 1 | 2016 | 32 | 0.030 |
Why?
|
| Seawater | 1 | 1997 | 124 | 0.030 |
Why?
|
| Clinical Trials, Phase I as Topic | 1 | 2018 | 326 | 0.030 |
Why?
|
| Viscosity | 2 | 2000 | 336 | 0.030 |
Why?
|
| Bacteria | 1 | 2007 | 2199 | 0.030 |
Why?
|
| Glutarates | 1 | 2018 | 243 | 0.030 |
Why?
|
| Arginine | 3 | 1999 | 934 | 0.030 |
Why?
|
| Appointments and Schedules | 1 | 2000 | 443 | 0.030 |
Why?
|
| Protozoan Proteins | 1 | 2002 | 847 | 0.030 |
Why?
|
| Gene Dosage | 1 | 2001 | 1218 | 0.030 |
Why?
|
| Neoplasms | 2 | 2003 | 22173 | 0.030 |
Why?
|
| Spectrophotometry, Infrared | 2 | 2013 | 117 | 0.030 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2000 | 1062 | 0.030 |
Why?
|
| Isoquinolines | 1 | 1997 | 352 | 0.030 |
Why?
|
| Artifacts | 2 | 2014 | 1911 | 0.030 |
Why?
|
| Apoproteins | 1 | 1995 | 45 | 0.030 |
Why?
|
| Phosphates | 3 | 2007 | 770 | 0.030 |
Why?
|
| Gene Rearrangement | 1 | 2001 | 1125 | 0.030 |
Why?
|
| Turkeys | 2 | 1992 | 45 | 0.030 |
Why?
|
| Glycolysis | 1 | 2000 | 835 | 0.030 |
Why?
|
| Europe | 1 | 2002 | 3420 | 0.030 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2004 | 2199 | 0.030 |
Why?
|
| Muscles | 6 | 1994 | 1576 | 0.030 |
Why?
|
| Amodiaquine | 1 | 2015 | 58 | 0.030 |
Why?
|
| Anilides | 2 | 1995 | 411 | 0.030 |
Why?
|
| Oxidopamine | 1 | 2015 | 172 | 0.030 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 2016 | 370 | 0.030 |
Why?
|
| Language | 1 | 2004 | 1543 | 0.030 |
Why?
|
| Transplantation, Autologous | 1 | 2020 | 2115 | 0.030 |
Why?
|
| High Mobility Group Proteins | 1 | 1995 | 177 | 0.030 |
Why?
|
| Manganese | 3 | 1998 | 393 | 0.030 |
Why?
|
| Nickel | 1 | 1995 | 128 | 0.030 |
Why?
|
| Probability | 3 | 1997 | 2477 | 0.030 |
Why?
|
| Immunoglobulin Variable Region | 3 | 1991 | 419 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2020 | 2626 | 0.030 |
Why?
|
| Cognition | 1 | 2012 | 6992 | 0.030 |
Why?
|
| Methylglucosides | 1 | 1994 | 35 | 0.030 |
Why?
|
| Glucosephosphates | 1 | 1994 | 19 | 0.030 |
Why?
|
| Cacodylic Acid | 1 | 1994 | 14 | 0.030 |
Why?
|
| Computer Graphics | 3 | 1994 | 340 | 0.030 |
Why?
|
| Mitochondria | 2 | 2005 | 3624 | 0.030 |
Why?
|
| Mercaptoethanol | 1 | 2013 | 62 | 0.030 |
Why?
|
| Alkylation | 1 | 1994 | 84 | 0.030 |
Why?
|
| Peptide Chain Elongation, Translational | 1 | 1994 | 31 | 0.030 |
Why?
|
| Endocytosis | 1 | 2018 | 957 | 0.030 |
Why?
|
| Peptide Elongation Factors | 1 | 1994 | 62 | 0.030 |
Why?
|
| Guanylyl Imidodiphosphate | 2 | 1990 | 37 | 0.030 |
Why?
|
| Alanine | 4 | 1998 | 609 | 0.030 |
Why?
|
| Chloroquine | 1 | 2015 | 274 | 0.030 |
Why?
|
| Biophysical Phenomena | 1 | 1994 | 320 | 0.030 |
Why?
|
| Hydrazines | 1 | 1995 | 224 | 0.030 |
Why?
|
| Frontal Lobe | 1 | 2020 | 1420 | 0.030 |
Why?
|
| Sulfhydryl Compounds | 2 | 2010 | 301 | 0.030 |
Why?
|
| Epoxy Compounds | 1 | 1994 | 137 | 0.030 |
Why?
|
| Apolipoprotein E4 | 1 | 2018 | 709 | 0.030 |
Why?
|
| Sulfates | 2 | 2000 | 380 | 0.030 |
Why?
|
| Photochemistry | 2 | 1991 | 239 | 0.030 |
Why?
|
| Paralysis | 1 | 2014 | 250 | 0.030 |
Why?
|
| Protein Biosynthesis | 1 | 2000 | 2112 | 0.030 |
Why?
|
| Cell Cycle | 1 | 2001 | 2932 | 0.030 |
Why?
|
| Carbohydrate Metabolism | 1 | 1994 | 263 | 0.030 |
Why?
|
| Dopamine | 1 | 2020 | 1607 | 0.030 |
Why?
|
| Cold Temperature | 3 | 2014 | 785 | 0.030 |
Why?
|
| Dependovirus | 1 | 2018 | 718 | 0.030 |
Why?
|
| Dihydroxyacetone Phosphate | 3 | 1991 | 14 | 0.030 |
Why?
|
| Thiamine | 1 | 2013 | 160 | 0.030 |
Why?
|
| Aspartic Acid Endopeptidases | 1 | 2014 | 311 | 0.030 |
Why?
|
| Cations, Divalent | 3 | 1998 | 168 | 0.030 |
Why?
|
| Isoenzymes | 1 | 2017 | 1687 | 0.030 |
Why?
|
| Ion Transport | 1 | 2013 | 319 | 0.030 |
Why?
|
| HeLa Cells | 1 | 2018 | 3094 | 0.020 |
Why?
|
| Inosine Monophosphate | 2 | 2002 | 7 | 0.020 |
Why?
|
| Massachusetts | 1 | 2005 | 8833 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2022 | 2979 | 0.020 |
Why?
|
| Random Allocation | 1 | 1996 | 2395 | 0.020 |
Why?
|
| Flavin-Adenine Dinucleotide | 1 | 1991 | 31 | 0.020 |
Why?
|
| Pyrones | 1 | 1991 | 35 | 0.020 |
Why?
|
| Phosphotyrosine | 1 | 1992 | 456 | 0.020 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2013 | 411 | 0.020 |
Why?
|
| Transplantation, Homologous | 1 | 2020 | 4807 | 0.020 |
Why?
|
| Phenylalanine | 1 | 2013 | 366 | 0.020 |
Why?
|
| Ovum | 1 | 1992 | 187 | 0.020 |
Why?
|
| Mucous Membrane | 1 | 2014 | 659 | 0.020 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2014 | 437 | 0.020 |
Why?
|
| Immunoglobulin Idiotypes | 1 | 1991 | 200 | 0.020 |
Why?
|
| Macrophage Activation | 1 | 2014 | 553 | 0.020 |
Why?
|
| Databases, Factual | 2 | 1998 | 7968 | 0.020 |
Why?
|
| Diminazene | 1 | 2010 | 3 | 0.020 |
Why?
|
| Pemoline | 1 | 2010 | 18 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2005 | 7828 | 0.020 |
Why?
|
| Electrochemistry | 1 | 1990 | 145 | 0.020 |
Why?
|
| Lyases | 1 | 1990 | 42 | 0.020 |
Why?
|
| Medicare | 1 | 2009 | 6770 | 0.020 |
Why?
|
| Maleimides | 1 | 2010 | 113 | 0.020 |
Why?
|
| Photosynthesis | 1 | 1990 | 68 | 0.020 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2000 | 2805 | 0.020 |
Why?
|
| Ribulose-Bisphosphate Carboxylase | 1 | 1990 | 18 | 0.020 |
Why?
|
| Repressor Proteins | 2 | 1995 | 2986 | 0.020 |
Why?
|
| Aspartate Carbamoyltransferase | 1 | 1990 | 19 | 0.020 |
Why?
|
| Genome-Wide Association Study | 1 | 2009 | 12690 | 0.020 |
Why?
|
| Gene Expression Regulation, Fungal | 2 | 2004 | 495 | 0.020 |
Why?
|
| Inclusion Bodies | 1 | 2011 | 281 | 0.020 |
Why?
|
| Calgranulin A | 1 | 1990 | 80 | 0.020 |
Why?
|
| Immunosuppressive Agents | 1 | 2003 | 4176 | 0.020 |
Why?
|
| Free Radical Scavengers | 1 | 1990 | 211 | 0.020 |
Why?
|
| Decarboxylation | 1 | 2009 | 7 | 0.020 |
Why?
|
| Protein Denaturation | 3 | 1997 | 242 | 0.020 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2021 | 3397 | 0.020 |
Why?
|
| Time Factors | 4 | 2009 | 39969 | 0.020 |
Why?
|
| Aged | 4 | 2024 | 169310 | 0.020 |
Why?
|
| Benzoin | 1 | 2008 | 1 | 0.020 |
Why?
|
| Pseudomonas aeruginosa | 3 | 1995 | 1277 | 0.020 |
Why?
|
| Neurogenesis | 1 | 2015 | 863 | 0.020 |
Why?
|
| Benzaldehydes | 1 | 2008 | 59 | 0.020 |
Why?
|
| Genetic Vectors | 1 | 2018 | 3396 | 0.020 |
Why?
|
| beta Catenin | 1 | 2013 | 1040 | 0.020 |
Why?
|
| Ions | 2 | 2000 | 256 | 0.020 |
Why?
|
| Microscopy, Electron | 1 | 2011 | 2561 | 0.020 |
Why?
|
| Chromatography, Liquid | 1 | 2012 | 983 | 0.020 |
Why?
|
| Oxidoreductases | 1 | 1990 | 413 | 0.020 |
Why?
|
| Heat-Shock Proteins | 2 | 2002 | 795 | 0.020 |
Why?
|
| Information Systems | 1 | 1989 | 396 | 0.020 |
Why?
|
| Sulfur | 1 | 1988 | 162 | 0.020 |
Why?
|
| Ubiquitin | 1 | 2012 | 839 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2016 | 3430 | 0.020 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2012 | 1076 | 0.020 |
Why?
|
| Alleles | 1 | 2018 | 6864 | 0.020 |
Why?
|
| Nitrogen | 1 | 1988 | 348 | 0.020 |
Why?
|
| Electricity | 1 | 1988 | 181 | 0.020 |
Why?
|
| Cell Death | 1 | 2012 | 1679 | 0.020 |
Why?
|
| Acylation | 1 | 2006 | 96 | 0.020 |
Why?
|
| GTP Phosphohydrolases | 1 | 1990 | 517 | 0.020 |
Why?
|
| Comamonas testosteroni | 1 | 2006 | 2 | 0.020 |
Why?
|
| Autoimmunity | 1 | 2014 | 1356 | 0.020 |
Why?
|
| Osteogenesis | 1 | 2013 | 1273 | 0.020 |
Why?
|
| Methods | 2 | 1985 | 1067 | 0.020 |
Why?
|
| Asparagine | 1 | 1986 | 119 | 0.020 |
Why?
|
| Surface Properties | 1 | 2009 | 1161 | 0.020 |
Why?
|
| DNA, Bacterial | 3 | 1996 | 1479 | 0.020 |
Why?
|
| Titrimetry | 1 | 2005 | 35 | 0.020 |
Why?
|
| Biological Transport | 1 | 1990 | 2091 | 0.020 |
Why?
|
| Lung | 1 | 2024 | 10002 | 0.020 |
Why?
|
| Placenta | 1 | 1994 | 1709 | 0.020 |
Why?
|
| Host-Pathogen Interactions | 1 | 2014 | 1459 | 0.020 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 2 | 1990 | 1745 | 0.020 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1987 | 779 | 0.020 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2012 | 1188 | 0.020 |
Why?
|
| Ultraviolet Rays | 1 | 1990 | 1080 | 0.020 |
Why?
|
| Metalloendopeptidases | 1 | 2007 | 393 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 1993 | 4111 | 0.020 |
Why?
|
| Viral Regulatory and Accessory Proteins | 1 | 1985 | 153 | 0.020 |
Why?
|
| Pressure | 1 | 1988 | 1154 | 0.020 |
Why?
|
| Isotopes | 1 | 1985 | 125 | 0.020 |
Why?
|
| Fructose-Bisphosphatase | 1 | 1984 | 25 | 0.020 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2002 | 9001 | 0.020 |
Why?
|
| Spectrophotometry, Atomic | 1 | 2004 | 82 | 0.010 |
Why?
|
| Neurospora crassa | 1 | 2004 | 27 | 0.010 |
Why?
|
| 1-Methyl-4-phenylpyridinium | 1 | 2004 | 34 | 0.010 |
Why?
|
| Motor Activity | 1 | 2014 | 2715 | 0.010 |
Why?
|
| Polyethylene Glycols | 3 | 1995 | 1189 | 0.010 |
Why?
|
| Globins | 1 | 1985 | 404 | 0.010 |
Why?
|
| Exons | 1 | 1990 | 2391 | 0.010 |
Why?
|
| Glycerol | 1 | 2005 | 274 | 0.010 |
Why?
|
| Phenylhydrazines | 1 | 1984 | 28 | 0.010 |
Why?
|
| Buffers | 1 | 1984 | 146 | 0.010 |
Why?
|
| Cytochrome c Group | 1 | 1984 | 122 | 0.010 |
Why?
|
| Phenotype | 1 | 2022 | 16592 | 0.010 |
Why?
|
| Pancreas | 3 | 1995 | 1691 | 0.010 |
Why?
|
| Citric Acid | 2 | 1994 | 123 | 0.010 |
Why?
|
| Positron-Emission Tomography | 1 | 2020 | 6484 | 0.010 |
Why?
|
| Flavodoxin | 1 | 1983 | 3 | 0.010 |
Why?
|
| Osteoporosis | 1 | 2013 | 1606 | 0.010 |
Why?
|
| Cations | 1 | 2004 | 238 | 0.010 |
Why?
|
| Flavoproteins | 1 | 1983 | 40 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2014 | 8181 | 0.010 |
Why?
|
| Isotope Labeling | 1 | 1985 | 392 | 0.010 |
Why?
|
| 3',5'-Cyclic-AMP Phosphodiesterases | 1 | 1983 | 48 | 0.010 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2012 | 2057 | 0.010 |
Why?
|
| Intracellular Membranes | 1 | 2004 | 389 | 0.010 |
Why?
|
| Cations, Monovalent | 1 | 2002 | 24 | 0.010 |
Why?
|
| COS Cells | 1 | 2005 | 1130 | 0.010 |
Why?
|
| Canavanine | 1 | 2002 | 14 | 0.010 |
Why?
|
| Cyanobacteria | 1 | 1983 | 52 | 0.010 |
Why?
|
| Comorbidity | 1 | 2018 | 10508 | 0.010 |
Why?
|
| Enzyme Activators | 1 | 2002 | 57 | 0.010 |
Why?
|
| Bone and Bones | 1 | 2013 | 2568 | 0.010 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2013 | 1642 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2012 | 4125 | 0.010 |
Why?
|
| Indicators and Reagents | 1 | 1983 | 462 | 0.010 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 2002 | 189 | 0.010 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 2002 | 283 | 0.010 |
Why?
|
| Avidin | 1 | 1982 | 43 | 0.010 |
Why?
|
| Regulon | 1 | 2002 | 71 | 0.010 |
Why?
|
| Cycloheximide | 1 | 2002 | 343 | 0.010 |
Why?
|
| Technology | 1 | 1985 | 292 | 0.010 |
Why?
|
| Sulfoxides | 1 | 2001 | 48 | 0.010 |
Why?
|
| Culture Media | 1 | 2004 | 897 | 0.010 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2011 | 1899 | 0.010 |
Why?
|
| Immunoglobulin Constant Regions | 2 | 1991 | 58 | 0.010 |
Why?
|
| Hippocampus | 1 | 2014 | 3766 | 0.010 |
Why?
|
| Disease Progression | 1 | 2018 | 13510 | 0.010 |
Why?
|
| Ferric Compounds | 2 | 2000 | 378 | 0.010 |
Why?
|
| Tritium | 2 | 1994 | 708 | 0.010 |
Why?
|
| Trehalose | 1 | 2001 | 88 | 0.010 |
Why?
|
| Endoribonucleases | 1 | 1983 | 228 | 0.010 |
Why?
|
| Spectrum Analysis, Raman | 1 | 1983 | 237 | 0.010 |
Why?
|
| Fluorescent Dyes | 1 | 2009 | 1903 | 0.010 |
Why?
|
| Chelating Agents | 1 | 2002 | 387 | 0.010 |
Why?
|
| Glycogen | 1 | 2001 | 251 | 0.010 |
Why?
|
| Diploidy | 1 | 2000 | 132 | 0.010 |
Why?
|
| Xanthine | 1 | 2000 | 11 | 0.010 |
Why?
|
| Spores, Fungal | 1 | 2000 | 90 | 0.010 |
Why?
|
| Methanol | 1 | 1981 | 92 | 0.010 |
Why?
|
| Glyceraldehyde 3-Phosphate | 2 | 1991 | 6 | 0.010 |
Why?
|
| Middle Aged | 3 | 2024 | 220921 | 0.010 |
Why?
|
| Ubiquitin-Conjugating Enzymes | 1 | 2001 | 200 | 0.010 |
Why?
|
| Ferrous Compounds | 1 | 2000 | 41 | 0.010 |
Why?
|
| Ovalbumin | 1 | 1982 | 677 | 0.010 |
Why?
|
| Hydroxylation | 1 | 2000 | 137 | 0.010 |
Why?
|
| Neurotransmitter Agents | 1 | 2004 | 665 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2012 | 10766 | 0.010 |
Why?
|
| G1 Phase | 1 | 2001 | 403 | 0.010 |
Why?
|
| Ligases | 1 | 2001 | 333 | 0.010 |
Why?
|
| Ribonucleotides | 1 | 2000 | 114 | 0.010 |
Why?
|
| Glass | 1 | 2000 | 115 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 2004 | 1699 | 0.010 |
Why?
|
| Cricetinae | 1 | 2003 | 2423 | 0.010 |
Why?
|
| Cyclins | 1 | 2001 | 594 | 0.010 |
Why?
|
| Curare | 1 | 1978 | 9 | 0.010 |
Why?
|
| Androstadienes | 1 | 2000 | 348 | 0.010 |
Why?
|
| Elapid Venoms | 1 | 1978 | 40 | 0.010 |
Why?
|
| Meiosis | 1 | 2000 | 328 | 0.010 |
Why?
|
| Electrons | 1 | 2000 | 265 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2020 | 39106 | 0.010 |
Why?
|
| Pyridoxamine | 1 | 1998 | 10 | 0.010 |
Why?
|
| Potassium | 1 | 2002 | 1311 | 0.010 |
Why?
|
| Protein Subunits | 1 | 2001 | 943 | 0.010 |
Why?
|
| Ketoglutaric Acids | 1 | 1998 | 76 | 0.010 |
Why?
|
| Endonucleases | 1 | 1981 | 371 | 0.010 |
Why?
|
| Cerebral Cortex | 1 | 2014 | 5779 | 0.010 |
Why?
|
| Calcium | 2 | 2003 | 5722 | 0.010 |
Why?
|
| Molecular Targeted Therapy | 1 | 2009 | 2811 | 0.010 |
Why?
|
| Erabutoxins | 1 | 1977 | 1 | 0.010 |
Why?
|
| Lithium | 1 | 2000 | 596 | 0.010 |
Why?
|
| Molecular Weight | 2 | 1995 | 2186 | 0.010 |
Why?
|
| Enzyme Repression | 1 | 1996 | 30 | 0.010 |
Why?
|
| Neurotoxins | 1 | 1978 | 240 | 0.010 |
Why?
|
| DNA, Fungal | 1 | 1998 | 275 | 0.010 |
Why?
|
| Pyruvic Acid | 1 | 1998 | 204 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2020 | 20568 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2014 | 22176 | 0.010 |
Why?
|
| Species Specificity | 2 | 1997 | 2414 | 0.010 |
Why?
|
| Nucleosides | 1 | 1997 | 131 | 0.010 |
Why?
|
| Organoplatinum Compounds | 1 | 1978 | 407 | 0.010 |
Why?
|
| Endoplasmic Reticulum | 1 | 2002 | 1134 | 0.010 |
Why?
|
| Transfection | 1 | 2004 | 5774 | 0.010 |
Why?
|
| Ethanol | 1 | 2002 | 1324 | 0.010 |
Why?
|
| Helix-Turn-Helix Motifs | 1 | 1995 | 14 | 0.010 |
Why?
|
| Guanidine | 1 | 1995 | 35 | 0.010 |
Why?
|
| Radiation Effects | 1 | 1975 | 69 | 0.010 |
Why?
|
| beta-Alanine | 1 | 1995 | 82 | 0.010 |
Why?
|
| Thiazoles | 1 | 2002 | 1517 | 0.010 |
Why?
|
| Cytosol | 1 | 1998 | 888 | 0.010 |
Why?
|
| Guanidines | 1 | 1995 | 194 | 0.010 |
Why?
|
| Inflammation | 1 | 2014 | 10774 | 0.010 |
Why?
|
| Colorectal Neoplasms | 1 | 2014 | 6938 | 0.010 |
Why?
|
| 3-O-Methylglucose | 1 | 1994 | 37 | 0.010 |
Why?
|
| Yeasts | 1 | 1995 | 279 | 0.010 |
Why?
|
| Calcium Gluconate | 1 | 1994 | 22 | 0.010 |
Why?
|
| Glucose-6-Phosphate | 1 | 1994 | 29 | 0.010 |
Why?
|
| Nucleotides | 1 | 1997 | 454 | 0.010 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 1998 | 1541 | 0.010 |
Why?
|
| Acetylglucosamine | 1 | 1975 | 189 | 0.010 |
Why?
|
| Mice, Inbred A | 1 | 1993 | 246 | 0.010 |
Why?
|
| Cell Division | 1 | 2001 | 4465 | 0.010 |
Why?
|
| Spectrometry, Fluorescence | 1 | 1996 | 685 | 0.010 |
Why?
|
| Carbon Monoxide | 1 | 1997 | 547 | 0.010 |
Why?
|
| Esters | 1 | 1994 | 211 | 0.010 |
Why?
|
| Urea | 1 | 1995 | 443 | 0.010 |
Why?
|
| Binding Sites, Antibody | 1 | 1993 | 337 | 0.010 |
Why?
|
| Oligosaccharides | 1 | 1975 | 406 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 1975 | 1625 | 0.010 |
Why?
|
| Child | 1 | 2020 | 80158 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2007 | 14665 | 0.010 |
Why?
|
| Fructose | 1 | 1994 | 288 | 0.010 |
Why?
|
| Chromatography, Thin Layer | 1 | 1992 | 213 | 0.010 |
Why?
|
| Carbohydrate Sequence | 1 | 1992 | 411 | 0.010 |
Why?
|
| Energy Transfer | 1 | 1991 | 108 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 1994 | 1991 | 0.010 |
Why?
|
| Particle Accelerators | 1 | 1991 | 174 | 0.010 |
Why?
|
| Serum Albumin | 1 | 1993 | 672 | 0.010 |
Why?
|
| Fourier Analysis | 1 | 1991 | 441 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2014 | 58984 | 0.010 |
Why?
|
| Restriction Mapping | 1 | 1990 | 851 | 0.010 |
Why?
|
| Kidney | 1 | 1984 | 7048 | 0.000 |
Why?
|
| Chromosome Mapping | 1 | 1997 | 4615 | 0.000 |
Why?
|
| Carbon Isotopes | 1 | 1988 | 458 | 0.000 |
Why?
|
| Isoelectric Point | 1 | 1987 | 76 | 0.000 |
Why?
|
| Leukemia | 1 | 1975 | 1522 | 0.000 |
Why?
|
| Synapses | 1 | 1976 | 1769 | 0.000 |
Why?
|
| Immunologic Techniques | 1 | 1987 | 212 | 0.000 |
Why?
|
| Half-Life | 1 | 1987 | 651 | 0.000 |
Why?
|
| Computers | 2 | 1977 | 593 | 0.000 |
Why?
|
| Plasmids | 1 | 1990 | 2269 | 0.000 |
Why?
|
| Myocardium | 1 | 1997 | 4725 | 0.000 |
Why?
|
| Flavin Mononucleotide | 1 | 1983 | 8 | 0.000 |
Why?
|
| Apoenzymes | 1 | 1983 | 17 | 0.000 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2010 | 36426 | 0.000 |
Why?
|
| Clostridium | 1 | 1983 | 100 | 0.000 |
Why?
|
| Scattering, Radiation | 1 | 1983 | 490 | 0.000 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 1990 | 2425 | 0.000 |
Why?
|
| Muscle, Skeletal | 1 | 1995 | 4948 | 0.000 |
Why?
|
| Receptors, Drug | 1 | 1978 | 157 | 0.000 |
Why?
|
| Nitrophenols | 1 | 1976 | 169 | 0.000 |
Why?
|
| Erythrocytes | 1 | 1983 | 2413 | 0.000 |
Why?
|
| Chloromercuribenzoates | 1 | 1972 | 5 | 0.000 |
Why?
|
| Trioses | 1 | 1972 | 3 | 0.000 |
Why?
|
| Ammonium Sulfate | 1 | 1972 | 30 | 0.000 |
Why?
|
| Amino Alcohols | 1 | 1972 | 19 | 0.000 |
Why?
|
| Acetone | 1 | 1972 | 44 | 0.000 |
Why?
|
| Organophosphorus Compounds | 1 | 1972 | 206 | 0.000 |
Why?
|
| Mercury | 1 | 1972 | 290 | 0.000 |
Why?
|
| Organometallic Compounds | 1 | 1972 | 647 | 0.000 |
Why?
|